Tempest Therapeutics
TPST
TPST
23 hedge funds and large institutions have $1.05M invested in Tempest Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
78% less capital invested
Capital invested by funds: $4.86M → $1.05M (-$3.81M)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$33.1K | |
| 2 | +$22.1K | |
| 3 | +$18.7K | |
| 4 |
Millennium Management
New York
|
+$8.27K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$5.12K |
Top Sellers
| 1 | -$279K | |
| 2 | -$142K | |
| 3 | -$72K | |
| 4 |
Renaissance Technologies
New York
|
-$11K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$8.25K |